The red cell's antioxidant generator — and the most common enzyme disorder in humans. G6PD runs the pentose phosphate pathway's first step, making the NADPH that keeps red blood cells from oxidizing apart.
An oxidoreductase, G6PD transfers hydride from glucose-6-phosphate's first carbon to NADP+, producing NADPH and committing sugar to the oxidative pentose phosphate pathway. The reaction is the rate-limiting, essentially irreversible entry point; the pentose products feed nucleotide synthesis while the NADPH feeds reductive biosynthesis and antioxidant defense.
Regulation
NADP+ availability is the dominant switch — oxidant stress drains NADPH, raises NADP+, and instantly accelerates the pathway.
Insulin induces G6PD expression after meals, matching NADPH supply to fatty acid biosynthesis demand.
Gene dosage matters: being X-linked, cells in female carriers are mosaics of active and inactive alleles.
Physiological Role
Its pathway is the only NADPH source in erythrocytes, which lack mitochondria — it keeps glutathione reduced and hemoglobin's iron from rusting.
Supplies NADPH for fatty-acid and steroid synthesis in liver, mammary gland, and adrenal cortex.
Its ribulose-5-phosphate product becomes ribose for DNA and RNA synthesis in dividing cells.
Interactions
Competes with glycolysis for glucose-6-phosphate, the shared branch-point metabolite.
Glutathione peroxidase and catalase consume the NADPH downstream; oxidant drugs stress the whole chain.
In neutrophils, NADPH feeds the NADPH oxidase that powers respiratory bursts — a parallel system with its own genetic disease.
Clinical Relevance
G6PD deficiency, the most common human enzymopathy, causes acute hemolysis after primaquine, fava beans, or infections.
The same mutations protect against falciparum malaria — the classic balancing-selection story.
Neonatal jaundice in deficient infants can be severe; screening is routine in endemic regions.
Because the gene sits on the X chromosome, carrier females are mosaics, and severity varies by lyonization.